email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2644-1373

LOJ Pharmacology & Clinical Research

Case Report(ISSN: 2644-1373)

A De Novo Mutation in TSC2 Gene is Associated with Tuberous Sclerosis Complex (TSC): A Case Report

Volume 2 - Issue 1

Weihua Zhan1, Jiangbo Li1, Yajie Zhao2, Jianli Zhang2, Yaxi Zhang2, Yanxia Mi2 and Jianxiong Duan2*

  • Author Information Open or Close
    • 1Chengdu Shenkang Epilepsy Hospital, Chengdu 610000, People’s Republic of China
    • 2Shanxi Guoxin Caregeno Medical Laboratory, Taiyuan 030006, People’s Republic of China

    *Corresponding author:Jianxiong Duan, Shanxi Guoxin Caregeno Medical Laboratory, Taiyuan 030006, People’s Republic of China, China

Received: July 03, 2020;   Published: July 08, 2020

DOI: 10.32474/LOJPCR.2020.02.000130

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Tuberous sclerosis, also known as tuberous sclerosis complex (TSC), is an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems including brain, skin, heart, kidneys, and lung. These changes can result in epilepsy, learning difficulties, behavioral problems, renal failure, and other complications [1,2]. The affected genes are TSC1 and TSC2, encoding hamartin and tuberin respectively. The hamartin tuberin complex inhibits the mammalian target of rapamycin (mTOR) pathway, which controls cell growth and proliferation [2]. In this case, we report a 21-year-old Chinese female patient with TSC due to a de-nove mutation c.1806C>G (p. Tyr602Ter) in TSC2 gene [3]. This is likely to be the first report of this mutation in Chinese population. This mutation was evaluated as a pathogenic mutation based on the standards and guidelines of ACMG (American College of Medical Genetics and Genomics).

Keywords: Chinese; Epilepsy; Tuberous sclerosis complex (TSC); Tuberous sclerosis-1 (TSC1); Tuberous sclerosis-2 (TSC2); de novo mutation; ACMG

Abstract| Introduction| Case Report| Discussion| Conclusion| Consent| Acknowledgments| References|

https://www.high-endrolex.com/21